Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767)
02/1999
02/03/1999EP0894093A2 Soluble tachykinin antagonists, the preparation and use thereof
02/03/1999EP0729352B1 Interdigitation-fusion liposomes containing arachidonic acid metabolites
02/03/1999CN1207097A Novel substituted 4-(1H-benzimidazol-2-YL) [1,4] diazepanes useful for the treatment of allergic diseases
02/03/1999CN1207044A Cyclosporin-containing soft capsule preparations
02/03/1999CN1206609A External medicine for curing respiratory tract disease
02/03/1999CN1041923C Piperzine derivatives and preparation process and usage thereof
02/02/1999US5866610 Substituted benzoylguanidines, process for their preparation, their use as a pharmaceutical as inhibitors of the cellular NA+/H+ exchange or as a diagnostic, and pharmaceutical containing them
02/02/1999US5866593 Potent and selective phosphodiesterase type iv inhibitors, useful in the prophylaxis and treatment of diseases such as asthma where an unwanted inflammatory response or muscular spasm is present.
02/02/1999US5866588 Dual histamine (h1) and platelet activating factor (paf) receptor antagonists.
02/02/1999US5866568 Heterocyclic compounds
02/02/1999US5866370 Polynucleotides and polypeptides of the m29 aminopeptidase family, hereinafter referred to as ?aminopeptidase.?
02/02/1999US5866366 gidB
02/02/1999US5866365 Utilizing rnc polypeptides to screen for antibacterial compounds.
02/02/1999CA2130464C Topical aromatic releasing compositions
02/01/1999CA2238670A1 A novel smad3 splice variant as a target in chronic renal failure, atherosclerosis and fibrosis
01/1999
01/29/1999CA2243882A1 Substituted indole-2-carboxylic acids as glucosyl transferase inhibitors
01/29/1999CA2239266A1 Novel histidine kinase
01/28/1999WO1999003987A2 Syncytial respiratory virus epitopes and antibodies comprising them, useful in diagnosis and therapy
01/28/1999WO1999003882A2 Human leukocyte calcium activated potassium channel polypeptide
01/28/1999DE19731571A1 Endothelin-Rezeptor-Antagonisten Endothelin receptor antagonists
01/28/1999DE19731472A1 Spray fluid useful for reducing swelling of nasal mucosa contains hyper-physiological or hyper-osmolar sodium chloride concentration
01/28/1999CA2296736A1 Syncytial respiratory virus epitopes and antibodies comprising them, useful in diagnosis and therapy
01/27/1999EP0893503A2 Regulator protein from Staphylococcus aureus
01/27/1999EP0893498A2 cDNA clone MY1 that encodes a novel human 7-transmembrane receptor
01/27/1999EP0893142A1 Mask for treating cold
01/27/1999EP0892809A1 Fhit proteins and nucleic acids and methods based thereon
01/27/1999EP0892791A1 Substituted benzenesulfonamide derivatives as prodrugs of cox-2 inhibitors
01/27/1999EP0892784A1 Aminoisoquinolines and aminothienopyridine derivatives and their use as anti-inflammatory agents
01/27/1999EP0892642A1 Use in a composition of an extract of at least one labiate
01/27/1999EP0731792B1 Heterocyclic benzenesulfonylimine derivatives as inhibitors of il-1 action
01/27/1999CN1206414A N-acyl-2-substituted-4-(benzimidazolyl-or imidazopyridinyl-substituted pesidues)-piperidines as tachykinin antagonists
01/27/1999CN1206405A Imides as PDE III, PDE IV and TNF inhibitors
01/27/1999CN1041830C Peptide compound
01/26/1999US5864045 Antiasthmatics, treatment of cough, bronchitis
01/26/1999US5864037 Dethionating, halogenating and aminating a 2-thiocarbonyl-6-oxo-3,8-disubstituted-1,2,3,6-tetrahydro-3h-purine to obtain the 6-amino derivative; bronchodilators; antiinflammatory agents
01/26/1999US5864036 Substituted imidazole compounds
01/26/1999US5863927 Dextromethorphan and an oxidase inhibitor for treating intractable conditions
01/26/1999US5863926 4,4-(disubstituted)cyclohexan-1-carboxylate monomers and related compounds
01/26/1999US5863889 ICAM-1/LFA-1 short-chain peptides and method of using same
01/26/1999US5863780 A polynucleotide sequence encodes human protein kinase polypeptide; culture product
01/26/1999US5863766 Isolated, pure polynucleotide encoding a polypeptide for treating vesicle trafficking, immunological, and neoplastic disorders.
01/26/1999US5863563 Administering a ph-raising buffer in powder form
01/26/1999CA2166692C Novel 9-n-bicyclic nucleoside agents useful as selective inhibitors of proinflammatory cytokines
01/26/1999CA2006511C Percutaneous preparation of tulobuterol
01/26/1999CA1340329C Superoxide dismutasee
01/25/1999CA2238664A1 Novel regulator
01/25/1999CA2238655A1 Cdna clone my1 that encodes a novel human 7-transmembrane receptor
01/23/1999CA2238665A1 Novel reductase
01/23/1999CA2238611A1 Novel lyss
01/23/1999CA2238608A1 Novel cyss
01/21/1999WO1999002547A1 Cytokine-, stress-, and oncoprotein-activated human protein kinase kinases
01/21/1999WO1999002505A1 Il-5 inhibiting 6-azauracil derivatives
01/21/1999WO1999002504A1 6-azauracil derivatives as il-5 inhibitors
01/21/1999WO1998046781A3 Novel transgene expression system for increased persistence
01/21/1999CA2294533A1 6-azauracil derivatives as il-5 inhibitors
01/21/1999CA2294145A1 Il-5 inhibiting 6-azauracil derivatives
01/20/1999EP0892064A2 Recombinant secA2 polypeptide from Staphylococcus aureus and uses thereof
01/20/1999EP0892063A2 Histidine kinase
01/20/1999EP0892062A2 The Chlamydia trachomatis Glutamyl-tRNAGln amidotransferase subunit ratC
01/20/1999EP0892059A2 Histidine kinase polypeptides
01/20/1999EP0892057A2 Response regulator
01/20/1999EP0892051A2 CDNA Clone heoad54 that encodes a human 7 transmembrane receptor
01/20/1999EP0891362A1 Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase
01/20/1999EP0891332A1 6-phenylpyridyl-2-amine derivatives
01/20/1999EP0891189A1 Medicament for optimising mucosal viscosity and stimulating intestinal function
01/20/1999EP0693053B1 Urea and amide derivatives and their use in the control of cell membrane potassium channels
01/20/1999CN1205335A Tricyclic diazepine vasopression antagonists
01/20/1999CN1205221A Balsam pear keeping-in-mouth tablet and its prepn. method
01/20/1999CN1205217A Pure Chinese medicinal syrup preparation and its production tech.
01/20/1999CN1205205A Pyrazolopyridine compound and processes for preparation thereof
01/19/1999US5861509 Neurokinin and tachykinin antagonists; respiratory system disorders, antiinflammatory agents
01/19/1999US5861481 Peptide lung surfactants and therapeutic combinations
01/19/1999US5861402 1,4-dihydropyridine compounds
01/19/1999US5861401 Treatment of congestive heart failure
01/19/1999US5861392 Therapeutic heterocycles
01/19/1999US5861380 Oxadiazole, thiadiazole and triazole peptoids as inhibitors of human neutrophil elastase; adult respiratory distress syndrome; antiarthritic,-inflammatory,-ischemic,-tumor and -carcinogenic agents and other hne-mediated conditions
01/19/1999US5861281 Lacc
01/18/1999CA2237050A1 Histidine kinase
01/18/1999CA2237043A1 Response regulator
01/14/1999WO1999001553A1 Murine and human cerberus-like proteins and compositions comprising them
01/14/1999WO1999001467A2 Therapeutically active compounds with low systemic activity due to reduce half life
01/14/1999WO1999001466A1 Secreted proteins and polynucleotides encoding them
01/14/1999WO1999001455A1 Compounds
01/14/1999WO1999001452A1 Novel cycloalkyl substituted imidazoles
01/14/1999WO1999001451A1 Azetidinylpropylpiperidine derivatives, intermediates and use as tachykinin antagonists
01/14/1999WO1999001444A1 Polymorphic form of the tachykinin receptor antagonist 2-(r)-(1-(r) -(3,5-bis(trifluoromethyl) phenyl)ethoxy)-3-(s)-(4-fluoro) phenyl-4-(3-5 (-oxo-1h,4h-1,2,4,-triazolo) methylmorpholine
01/14/1999WO1999001137A1 Azelastine hydrochloride-containing percutaneous preparation having good percutaneous absorbability and reduced skin irritation
01/14/1999WO1999001136A1 Novel substituted imidazole compounds
01/14/1999WO1999001131A1 Novel substituted imidazole compounds
01/14/1999WO1999001130A1 Novel substituted imidazole compounds
01/14/1999WO1999001127A1 Compounds and methods
01/14/1999WO1999001033A1 Compositions and methods for reducing respiratory depression and attendant side effects of mu opioid compounds
01/14/1999DE19729561A1 Use of Capsicum annuum composition in homeopathy
01/14/1999CA2295762A1 Novel cycloalkyl substituted imidazoles
01/14/1999CA2295228A1 Novel substituted imidazole compounds
01/14/1999CA2295212A1 Secreted proteins and polynucleotides encoding them
01/14/1999CA2294770A1 Compounds and methods
01/14/1999CA2294734A1 Compounds
01/14/1999CA2294524A1 Novel substituted imidazole compounds
01/14/1999CA2294522A1 Novel substituted imidazole compounds